Senseonics (SENS): Enterprise Value to EBITDA Ratio
This chart illustrating the price evolution of the EV/EBITDA multiple for Senseonics Holdings (SENS) is fixed at 0.00. The business operates in a stable environment, as the humanitarian status of medicine offsets external political shocks. Senseonics Holdings (SENS) develops breakthrough fluorescent glucose sensors and accompanying software. Growth is driven by the implementation of annual sensors, the partnership with Ascensia, and the expansion of the CGM system user base.
Comprehensive metric breakdowns and analytics for Senseonics Corp (SENS)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
SENS - Net Financial Result|Projected Future Earnings Senseonics Holdings|SENS - Price to Earnings Ratio|Forward P/E Multiple senseonics.com|SENS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Senseonics Holdings, Inc.|SENS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Senseonics|SENS - Earnings per share for the trailing year|Quarterly EPS earnings growth senseonics.com|SENS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Senseonics Holdings
- sales volume and revenue indicators:
Analysis of all company metrics:Senseonics Holdings Inc SENS
For Senseonics Holdings (SENS), which develops long-term CGM sensors, the EV/EBITDA ratio chart with historical data serves as a tool for business valuation that accounts for debt load. This metric compares the Enterprise Value with operating profit before depreciation and amortization. A decrease in this value indicates that the asset is undervalued relative to its ability to generate cash flow. It is critical for investors to monitor this balance to avoid freezing capital in overvalued debt obligations.
Competitor analysis
Dexcom CGM - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra, Inc.)|NOVT: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Haemonetics HAE|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (conmed.com) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Biosciences (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode)|Enterprise Value to EBITDA Ratio Picard Medical PMI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics Inc. SRDX|NPCE - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA Sanuwave Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR Inc) - EV/EBITDA Multiple|AVITA Medical, Inc (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio Baird Medical BDMD|EV/EBITDA Multiple EDAP (EDAP TMS SA)|EV/EBITDA Multiple Apyx Medical APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (TELA Bio Corp) - Enterprise Value to EBITDA Ratio|CytoSorbents Corp - Business Value to Operating Income Before Depreciation|SRTS (Sensus) - EV/EBITDA Multiple|Company Value to EBITDA Zynex Medical ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies Oxy B.H.N. Ltd. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio seastarmedical.com (ICU)|IRIDEX Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions Inc. INBS|Beyond Air (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa, Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization strataskinsciences.com|Enterprise Value to EBITDA Ratio GlucoTrack, Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis, Inc. NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Cutera, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization knowlabs.co|Enterprise Value to Operating Income Before Depreciation NARI (Inari)|Enterprise Value to EBITDA Ratio NVRO (Nevro Corp.)|Total Company Value to Operating Income Before Depreciation Ratio ReShape Lifesciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization silkroadmed.com SILK
